Bruker Corp. Stock
Price
Target price
€40.14
€40.14
2.720%
1.06
2.720%
€48.54
10.12.25 / Tradegate
WKN: 813534 / Symbol: BRKR / Name: Bruker / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Bruker Corp. Stock
Bruker Corp. gained 2.720% today.
Bruker Corp. is currently one of the favorites of our community with 16 Buy predictions and no Sell predictions.
With a target price of 48 € there is a slightly positive potential of 19.58% for Bruker Corp. compared to the current price of 40.14 €.
Our community identified positive and negative aspects for Bruker Corp. stock for the coming years. 0 users see the criterium "Revenue growth" as a plus for the Bruker Corp. stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Bruker Corp. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bruker Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | 2.720% | -2.145% | 13.808% | -29.579% | -27.624% | - | - |
| Integer Hldg | - | 2.521% | 3.390% | -53.788% | -51.969% | -10.294% | -0.813% |
| Healthequity Inc. | 1.900% | -4.819% | -1.863% | -11.236% | -13.187% | 29.508% | 49.057% |
| Omnicell Inc. | 1.610% | 8.140% | 17.722% | -16.216% | -10.577% | -16.964% | -59.565% |
Comments
Bruker (NASDAQ:BRKR) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $60.00 price target on the stock.
Show more
Ratings data for BRKR provided by MarketBeat
Bruker (NASDAQ:BRKR) is now covered by analysts at Rothschild & Co Redburn. They set a "buy" rating and a $60.00 price target on the stock.
Show more
Ratings data for BRKR provided by MarketBeat
Bruker (NASDAQ:BRKR) had its price target lowered by analysts at Wells Fargo & Company from $50.00 to $48.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for BRKR provided by MarketBeat
News
Why Bruker Stock Slumped Monday
Bruker (NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the company's stock took something of a hit. Its price fell nearly 1% by the
Why This Investment Advisor Sold Off Its $3.6 Million Bruker Stake
On Tuesday, Massachusetts-based Lane Generational disclosed that it sold out of Bruker (NASDAQ:BRKR), liquidating 87,607 shares for an estimated $3.6 million in the third quarter.
According to a
Why Bruker Stock Tumbled by Almost 12% Wednesday
Medical device and diagnostics company Bruker (NASDAQ: BRKR) wasn't looking like the cure for any investor's ailments on Wednesday. The stock was hit with an assertive sell-off from the market